Bibliographie (2530)
Antibody evasion by the P.1 strain of SARS-CoV-2
mercredi, 31 mars 2021 09:29 Écrit par Zouhair SouissiAntibody evasion by the P.1 strain of SARS-CoV-2 – Cell Commentary on Twitter (thread – Click for more) An in-depth assessment of the P.1 (Brazil) variant —less immune evasion than B.1.351 (South Africa) variant despite similar receptor binding domain mutations—very good neutralization by mRNA vaccine via sera from vaccineshttps://t.co/2m0A1Pjs9O @CellCellPress today pic.twitter.com/uyV2eZdLQ9 — Eric […]
The post Antibody evasion by the P.1 strain of SARS-CoV-2 appeared first on Links Medicus.
![[Preprint] Single dose of AstraZeneca and Pfizer vaccines shows 62% efficacy for preventing disease and reduces viral load/transmissibility of SARS-CoV-2 in residents of Long-Term Care Facilities](/media/k2/items/cache/eb63149d9c12ea56cb5de9879451c7b7_L.jpg)
[Preprint] Single dose of AstraZeneca and Pfizer vaccines shows 62% efficacy for preventing disease and reduces viral load/transmissibility of SARS-CoV-2 in residents of Long-Term Care Facilities
mercredi, 31 mars 2021 09:29 Écrit par Zouhair SouissiVaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of Long-Term Care Facilities (VIVALDI study) – medRxiv Commentaries: Single dose of Pfizer and Oxford vaccines shows 60% efficacy in elderly care home residents – NewsMedical AND Care home residents gain 62% protection from single dose of COVID-19 vaccine […]
The post [Preprint] Single dose of AstraZeneca and Pfizer vaccines shows 62% efficacy for preventing disease and reduces viral load/transmissibility of SARS-CoV-2 in residents of Long-Term Care Facilities appeared first on Links Medicus.
‘Real world’ study by CDC shows Pfizer and Moderna vaccines were 90% effective
mardi, 30 mars 2021 08:26 Écrit par Zouhair Souissi‘Real world’ study by CDC shows Pfizer and Moderna vaccines were 90% effective – STAT Original Study: Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021 – Centers for Disease […]
The post ‘Real world’ study by CDC shows Pfizer and Moderna vaccines were 90% effective appeared first on Links Medicus.
Study: mRNA vaccine is associated with decreased SARS-CoV-2 viral load in individuals with breakthrough infection, suggesting a role in suppressing onward transmission
mardi, 30 mars 2021 08:26 Écrit par Zouhair SouissiInitial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine – Nature Medicine Commentaries on Twitter A study in @NatureMedicine reports that breakthrough SARS-CoV-2 infections occurring 12 or more days after the first dose of the Pfizer-BioNTech vaccine had lower viral loads, suggesting the vaccine might reduce infectiousness. https://t.co/yskN9lgiwr pic.twitter.com/LQVESgRjZz — […]
The post Study: mRNA vaccine is associated with decreased SARS-CoV-2 viral load in individuals with breakthrough infection, suggesting a role in suppressing onward transmission appeared first on Links Medicus.
Effect of timing of intubation on clinical outcomes of critically ill patients with COVID-19: a systematic review and meta-analysis of non-randomized cohort studies
mardi, 30 mars 2021 05:23 Écrit par Zouhair SouissiEffect of timing of intubation on clinical outcomes of critically ill patients with COVID-19: a systematic review and meta-analysis of non-randomized cohort studies – Critical Care Commentary on Twitter Proud to present our meta-analysis of a highly-debated topic! The synthesized evidence of almost 9000 critically ill patients with #COVID_19 suggests that #early_intubation, as suggested […]
The post Effect of timing of intubation on clinical outcomes of critically ill patients with COVID-19: a systematic review and meta-analysis of non-randomized cohort studies appeared first on Links Medicus.
M-A: Decreased mortality in acute respiratory distress syndrome patients treated with corticosteroids
mardi, 30 mars 2021 05:23 Écrit par Zouhair SouissiDecreased mortality in acute respiratory distress syndrome patients treated with corticosteroids: an updated meta-analysis of randomized clinical trials with trial sequential analysis – Critical Care
The post M-A: Decreased mortality in acute respiratory distress syndrome patients treated with corticosteroids appeared first on Links Medicus.
COVID associated with hearing loss, tinnitus and vertigo – new study confirms link
mardi, 30 mars 2021 05:23 Écrit par Zouhair SouissiCOVID associated with hearing loss, tinnitus and vertigo – new study confirms link – The Conversation Original study: One year on: an updated systematic review of SARS-CoV-2, COVID-19 and audio-vestibular symptoms – International Journal of Audiology
The post COVID associated with hearing loss, tinnitus and vertigo – new study confirms link appeared first on Links Medicus.
COVID-19, Personal Protective Equipment, and Human Performance
mardi, 30 mars 2021 05:23 Écrit par Zouhair SouissiCOVID-19, Personal Protective Equipment, and Human Performance – Anesthesiology
The post COVID-19, Personal Protective Equipment, and Human Performance appeared first on Links Medicus.
Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review
lundi, 29 mars 2021 03:28 Écrit par Zouhair SouissiInterleukin‐6 blocking agents for treating COVID‐19: a living systematic review – Cochrane Library Commentary on Twitter JUST PUBLISHED – Interleukin‐6 blocking agents for treating #COVID19 https://t.co/pt8BNfBwa3 New living systematic review from @Cochrane_ACE looks at the evidence from 10 studies in 6896 people with COVID‐19 pic.twitter.com/hjs97lPBEt — Cochrane UK (@CochraneUK) March 26, 2021
The post Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review appeared first on Links Medicus.
RCT: Discontinuing β-lactam treatment after 3 days as good as 8 days of treatment for stable patients with community-acquired pneumonia in non-critical care wards
lundi, 29 mars 2021 03:28 Écrit par Zouhair SouissiDiscontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial – The Lancet Commentary on Twitter Less can be more for pneumonia. In 50% CAP patients was possible stop Abx at 3 days and outcomes were the same @TheLancet https://t.co/Hc1AxyndWS pic.twitter.com/Ypk2uXeDQV — […]
The post RCT: Discontinuing β-lactam treatment after 3 days as good as 8 days of treatment for stable patients with community-acquired pneumonia in non-critical care wards appeared first on Links Medicus.
